Your browser doesn't support javascript.
loading
Individualized dosing with axitinib: rationale and practical guidance.
Schmidinger, Manuela; Danesi, Romano; Jones, Robert; McDermott, Ray; Pyle, Lynda; Rini, Brian; Négrier, Sylvie.
Afiliación
  • Schmidinger M; Clinical Division of Oncology, Department of Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Danesi R; Department of Clinical & Experimental Medicine, University of Pisa, Pisa, Italy.
  • Jones R; Institute of Cancer Sciences, University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • McDermott R; Department of Medical Oncology, St Vincent's University Hospital & The Adelaide & Meath Hospital, Dublin, Ireland.
  • Pyle L; Renal Cancer Unit, Department of Medicine, Royal Marsden Hospital, London, UK.
  • Rini B; Department of Hematology & Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Négrier S; Medical Oncology Department, University of Lyon, Centre Léon Bérard, Lyon, France.
Future Oncol ; 14(9): 861-875, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29264944
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Factor A de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Imidazoles / Indazoles Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Future Oncol Año: 2018 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Factor A de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Imidazoles / Indazoles Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Future Oncol Año: 2018 Tipo del documento: Article País de afiliación: Austria